BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986463 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986463\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06476808-2407@assetmemo.bio
DTSTAMP:20261121T005413Z
DTSTART;VALUE=DATE:20281219
DTEND;VALUE=DATE:20281220
SUMMARY:BMS-986463: Phase 1 readout est. (NCT06476808)
DESCRIPTION:BMS-986463\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A St
 udy to Evaluate the Safety\, Tolerability\, and Efficacy of Escalating Dos
 es of BMS-986463 in Participants With Select Advanced Malignant Tumors.\nE
 stimated primary completion: 19 December 2028. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/bms-986463#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06476808
URL:https://assetmemo.bio/drug/bms-986463#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
